SmartMD 2 minute Health update, (SACKID group Dr. Prakasam): Dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) - for type 1 DM

Monday, April 14, 2014

Dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) - for type 1 DM

Dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) - for type 1 DM

The company told investors the drug achieved the primary endpoint of the trial, and reduced mealtime insulin use. It also met several secondary endpoints, Lexicon said, including improved blood sugar control.

The company told investors the drug achieved the primary endpoint of the trial, and reduced mealtime insulin use. It also met several secondary endpoints, Lexicon said, including improved blood sugar control.

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)